SCOPUS 정보 검색 플랫폼

Volumn 29, Issue 16, 2011, Pages 2266-2272

Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: When differences have an impact on clinical practice

(5) Trotta, Francesco a Leufkens, Hubert G M b,c Schellens, Jan H M b,c,d Laing, Richard e Tafuri, Giovanni a,b

a ITALIAN MEDICINES AGENCY (Italy)

b UTRECHT UNIVERSITY (Netherlands)

c MEDICINES EVALUATION BOARD (Netherlands)

d NETHERLANDS CANCER INSTITUTE (Netherlands)

e WORLD HEALTH ORGANIZATION (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; BORTEZOMIB; BUSULFAN; CETUXIMAB; ERLOTINIB; IMATINIB; IRINOTECAN; MELPHALAN; PEMETREXED; PLACEBO; PREDNISONE; SORAFENIB; TEMSIROLIMUS; TRASTUZUMAB;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PRACTICE; COLORECTAL CANCER; DRUG APPROVAL; DRUG SCREENING; DRUG USE; EUROPEAN MEDICINES AGENCY; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; HEAD AND NECK CANCER; HEALTH CARE ORGANIZATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MULTIPLE MYELOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UNITED STATES;

ANTINEOPLASTIC AGENTS; DRUG APPROVAL; EUROPE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79957965504 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2010.34.1248 Document Type: Article

Times cited : (62)

References (22)

1
- 79957937898
- Mijuk G: Roche cancer drugs show positive results. http://online.wsj.com/ article/SB10001424052748703794104575545991869069562.html
- Roche Cancer Drugs Show Positive Results
- Mijuk, G.¹

2
- 79957950754
- Sotvall S: Sanofi's diabetes drug shows promise. http://online.wsj.com/ article/SB10001424052748704483004575523292705499992.html?KEYWORDS= sanofi+diabetes
- Sanofi's Diabetes Drug Shows Promise
- Sotvall, S.¹

3
- 79957967619
- Winslow R: Worries about using Plavix with heartburnpillsmaybeoverblown. http://online.wsj.com/article/SB10001424052748704689804575536381114294548.html
- Worries about Using Plavix with Heartburnpillsmaybeoverblown
- Winslow, R.¹

4
- 79957957206
- Harding A: Adults' suicide risk similar for all antidepressants. http://www.reuters.com/article/idUSTRE6435IM20100504
- Adults' Suicide Risk Similar for All Antidepressants
- Harding, A.¹

5
- 84900630965
- Australian Government, Department of Health and Ageing
- Australian Government, Department of Health and Ageing: Sibutramine (Reductil) withdrawal in Australia. http://www.tga.gov.au/alerts/medicines/ reductilwithdrawal.htm
- Sibutramine (Reductil) Withdrawal in Australia

6
- 79957929060
- Saudi Food and Drug Authority
- Saudi Food and Drug Authority: Using rituximab and incidence of progressive multifocal leukoencephalopathy. http://www.sfda.gov.sa/En/Drug/News/ 657-en-28-10.htm
- Using Rituximab and Incidence of Progressive Multifocal Leukoencephalopathy

7
- 79958259772
- Directorate General of Health Services, Office of Drug Controller General of India: File No. 12-1/10-DC (Pt. 18). New Delhi, India, Office of Drug Controller General
- Directorate General of Health Services, Office of Drug Controller General of India: Suspension of import/manufacture of rosiglitazone in the country. File No. 12-1/10-DC (Pt. 18). New Delhi, India, Office of Drug Controller General
- Suspension of Import/manufacture of Rosiglitazone in the Country

8
- 77957952617
- Regulatory action on rosiglitazone by the U.S. Food and Drug Administration
- Woodcock J, Sharfstein JM, Hamburg M: Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. N Engl J Med 363:1489-1491, 2010
- (2010) N Engl J Med , vol.363 , pp. 1489-1491
- Woodcock, J.¹ Sharfstein, J.M.² Hamburg, M.³

9
- 77957370174
- Insiders criticise FDA's decision not to withdraw rosiglitazone
- Cohen D: Insiders criticise FDA's decision not to withdraw rosiglitazone. BMJ 341:c5333, 2010
- (2010) BMJ , vol.341
- Cohen, D.¹

10
- 78649652460
- European Medicines Agency: European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim. http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news-and-events/news/2010/09/news-detail-001119. jsp&murl=menus/news-and-events/news-and-events.jsp&mid= WC0b01ac058004d5c1&jsenabled=true
- European Medicines Agency Recommends Suspension of Avandia, Avandamet and Avaglim

11
- 79957933688
- European Medicines Agency: Medicines regulators on both sides of the Atlantic confirm commitment to cooperation on medicines. http://www.ema.europa. eu/docs/en-GB/document-library/Press-release/2009/11/WC500007395.pdf
- Medicines Regulators on Both Sides of the Atlantic Confirm Commitment to Cooperation on Medicines

12
- 84884233637
- European Medicines Agency: General principles: EMA-FDA parallel scientific advice. http://www.ema.europa.eu/docs/en-GB/document-library/Other/ 2009/11/WC500014868.pdf
- General Principles: EMA-FDA Parallel Scientific Advice

13
- 79957938328
- European Medicines Agency: European Medicines Agency and US Food and Drug Administration extend confidentiality arrangements indefinitely. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2010/09/ news-detail-001112.jsp&murl=menus/news-and-events/news-and-events. jsp&mid=WC0b01ac058004d5c1
- European Medicines Agency and US Food and Drug Administration Extend Confidentiality Arrangements Indefinitely

14
- 0024467891
- The drug lag: An update of new drug introductions in the United States and in the United Kingdom, 1977 through 1987
- Kaitin KI, Mattison N, Northington FK, et al: The drug lag: An update of new drug introductions in the United States and in the United Kingdom, 1977 through 1987. Clin Pharmacol Ther 46:121-138, 1989
- (1989) Clin Pharmacol Ther , vol.46 , pp. 121-138
- Kaitin, K.I.¹ Mattison, N.² Northington, F.K.³

15
- 75149190109
- Therapeutic indications in oncology: Emerging features and regulatory dynamics
- Tafuri G, Leufkens HG, Laing R, et al: Therapeutic indications in oncology: Emerging features and regulatory dynamics. Eur J Cancer 46:471-475, 2010
- (2010) Eur J Cancer , vol.46 , pp. 471-475
- Tafuri, G.¹ Leufkens, H.G.² Laing, R.³

16
- 79957950289
- Homepage
- European Medicines Agency: Homepage. http://www.ema.europa.eu

17
- 77955798710
- US Food and Drug Administration: Drugs@FDA. http://www.accessdata.fda. gov/scripts/cder/drugsatfda/
- Drugs@FDA

18
- 77953955207
- Transparency at the Food and Drug Administration
- Asamoah AK, Sharfstein JM: Transparency at the Food and Drug Administration. N Engl J Med 362:2341-2343, 2010
- (2010) N Engl J Med , vol.362 , pp. 2341-2343
- Asamoah, A.K.¹ Sharfstein, J.M.²

19
- 77951045923
- Europe's opportunity to open up drug regulation
- Garattini S, Bertele' V: Europe's opportunity to open up drug regulation. BMJ 340:c1578, 2010
- (2010) BMJ , vol.340
- Garattini, S.¹ Bertele, V.²

20
- 79957968974
- Mundy A: Roche drug faces FDA curb. http://online.wsj.com/article/ SB10001424052748704073804576023512609387864.html?KEYWORDS= avastin#articleTabs%3Darticle
- Roche Drug Faces FDA Curb
- Mundy, A.¹

21
- 84925505803
- European Medicines Agency: European Medicines Agency completes its review of Avastin used in breast cancer. http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/public-health-alerts/2010/12/human-pha-detail-000023. jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d126
- European Medicines Agency Completes Its Review of Avastin Used in Breast Cancer

22
- 34247463760
- Paying for drug approvals: Who's using whom?
- Avorn J: Paying for drug approvals: Who's using whom? N Engl J Med 356:1697-1700, 2007
- (2007) N Engl J Med , vol.356 , pp. 1697-1700
- Avorn, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.